Non-invasive glucose Position Liom as a leader in non-invasive glucose monitoring wearable technology to target healthcare providers, wellness clinics, and preventive care programs interested in early metabolic risk detection.

Series A traction Leverage recent Series A1 and funding rounds to approach strategic investors, hospital networks, and corporate wellness partners seeking proven growth and validated technology for scale.

Small but agile Target mid-sized health tech distributors and direct-to-consumer channels that benefit from Liom's compact team size, rapid iteration capabilities, and potential for co-development with device manufacturers.

Global expansion Explore partnerships with European and global health systems to integrate Liom’s precision monitoring into chronic disease prevention programs, remote monitoring services, and payer-enabled models.

Tech ecosystem Highlight Liom’s tech stack and cloud capabilities to potential integrators and OEMs, offering opportunities for data analytics collaborations, platform integrations, and joint go-to-market initiatives.